WEST PHARMACEUTICAL SERVICES, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $43.90 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $43.90M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $28.90M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $22.70M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $31.40M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2025-12-31 | $43.90M 10-K · filed 2026-02-17 |
| 2024-12-31 | $28.90M 10-K · filed 2026-02-17 |
| 2023-12-31 | $22.70M 10-K · filed 2025-02-18 |
| 2022-12-31 | $31.40M 10-K · filed 2024-02-20 |
| 2021-12-31 | $31.60M 10-K · filed 2023-02-21 |
| 2020-12-31 | $35.30M 10-K · filed 2022-02-22 |
| 2019-12-31 | $25.60M 10-K · filed 2021-02-23 |
| 2018-12-31 | $27.20M 10-K · filed 2020-02-24 |
| 2017-12-31 | $28.30M 10-K · filed 2019-02-28 |
| 2016-12-31 | $46.40M 10-K · filed 2018-02-26 |
| 2015-12-31 | $42.00M 10-K · filed 2017-02-28 |
| 2014-12-31 | $43.70M 10-K · filed 2016-02-26 |
| 2013-12-31 | $51.20M 10-K · filed 2015-02-25 |
| 2012-12-31 | $69.80M 10-K · filed 2014-02-27 |
| 2011-12-31 | $62.30M 10-K · filed 2013-02-27 |
| 2010-12-31 | $48.60M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |